Market News AIOpen the app

Mubadala Investment Company sold its shares in Bristol-Myers Squibb, according to a filing with the SEC.

MarketRead the original at moomoo.com
Neutral

Mubadala ended its stake in Bristol-Myers Squibb, changing who owns its shares. The report describes no change to BMY's business or finances, so it does not change the company's outlook.

BMY · Bristol-Myers Squibb Company

AI read · Neutral

The AI's read

This changes who owns BMY shares, not the drugmaker's business. The report gives no size for the stake or reason for the sale, and describes no change to BMY's sales, products, or finances. It does not show a change to the company's outlook.

Get alerts for BMY

Follow Bristol-Myers Squibb Company (BMY) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for BMY
Free on the App Store and Google Play, or on the web.